Medical and surgical instruments, equipment, and supplies

Ended Awarded

Contract number
HHSN26300721
Awardee
Awarding agency
Obligated
$11,063

Award facts

Contract value 100% obligated
$11,063.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Valencia, CA 91355, USA

Award details come from SAM.gov/FPDS.

About this award

Qiagen, LLC, a Maryland-based molecular diagnostics manufacturer and subsidiary of Netherlands-headquartered Qiagen N.V., received a Blanket Purchase Agreement (BPA) call award valued at $11,063.40 for medical and surgical instruments, equipment, and supplies. The contract was awarded on December 11, 2014, by a civilian federal agency under the Office of the Director, with performance to be completed by December 31, 2014, at a location in Valencia, California. This award was issued under a firm fixed-price structure with no set-aside designation, reflecting the company's competitive position in the open federal marketplace. The contract represents a call against an existing BPA vehicle, enabling efficient procurement of specialized products from Qiagen's portfolio of molecular diagnostics and laboratory equipment.

Qiagen maintains a substantial federal contract presence across multiple agencies, including the Department of Health and Human Services, Department of Veterans Affairs, Department of Defense, and Federal Bureau of Investigation, where the company provides critical molecular diagnostics products, reagents, and instrumentation. The company's federal offerings include DNA and RNA extraction kits, next-generation sequencing equipment, digital polymerase chain reaction systems, tuberculosis testing reagents, and bioinformatics software. This particular BPA call supports the government's procurement objectives for specialized medical and scientific instruments, consistent with Qiagen's established role as a primary supplier of molecular diagnostics technologies to federal agencies engaged in research, healthcare delivery, and public health initiatives.

Quick answers

Who was awarded contract HHSN26300721?

HHSN26300721 was awarded to Qiagen, LLC by Office of the Director (National Institutes of Health) on December 11, 2014.

How much is contract HHSN26300721 worth?

The government has obligated $11,063 on HHSN26300721.

Is contract HHSN26300721 an order under another contract?

Yes. HHSN26300721 is a BPA call under HHSN263200100054095B, a blanket purchase agreement.

Was contract HHSN26300721 competed?

The extent of competition for HHSN26300721 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award